Vijoice
Generic name: Alpelisib
Dosage form: tablets
Drug class:
PI3K inhibitors
Usage of Vijoice
Vijoice is a prescription medicine used to treat adults and children 2 years of age and older with severe phosphatidylinositol-3-kinase catalytic subunit alpha (PIK3CA)-Related Overgrowth Spectrum (PROS).
It is not known if this medicine is safe and effective in children below 2 years of age.
Vijoice side effects
Vijoice may cause serious side effects, including:
Your healthcare provider may tell you to decrease your dose, temporarily stop your treatment, or completely stop your treatment if you get certain serious side effects.
The most common side effects include:
Vijoice may affect fertility in males and in females who are able to become pregnant. Talk to your healthcare provider if this is a concern for you. These are not all of the possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Vijoice
You should not take Vijoice if you have had a severe allergic reaction to alpelisib or are allergic to any of the ingredients.
Relate drugs
- Aliqopa
- Alpelisib
- Copanlisib
- Copiktra
- Duvelisib
- Idelalisib
- Joenja
- Piqray
- Piqray 200MG Daily Dose
- Piqray 250MG Daily Dose
- Piqray 300MG Daily Dose
- Vijoice
- Zydelig
How to use Vijoice
Usual Adult Dosage for PIK3CA-Related Overgrowth Spectrum
- 250 mg taken orally once daily with food.
- Use: treatment of adult patients with severe manifestations of PIK3CARelated Overgrowth Spectrum (PROS) who require systemic therapy.
Usual Pediatric Dosage for PIK3CA-Related Overgrowth Spectrum
- 50 mg taken orally once daily with food.
- Use: treatment of pediatric patients (2 years to less than 18 years of age) with severe manifestations of PIK3CARelated Overgrowth Spectrum (PROS) who require systemic therapy.
What other drugs will affect Vijoice
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Vijoice and other medicines may affect each other causing side effects. Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get a new medicine.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions